Corbenic Partners’s CVS Health CVS Stock Holding History

Corbenic Partners’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$8.05M	Sell	86,888 -800	-0.9%	-$78.1K	2.12%	16
2022 Q1	$8.88M	Sell	87,688 -5,281	-6%	-$555K	1.93%	13
2021 Q4	$9.59M	Buy	92,969 +1,967	+2%	+$182K	1.86%	9
2021 Q3	$7.72M	Buy	91,002 +10,068	+12%	+$843K	1.87%	10
2021 Q2	$6.75M	Buy	80,934 +1,445	+2%	+$118K	1.77%	10
2021 Q1	$5.98M	Buy	79,489 +7,902	+11%	+$576K	1.53%	12
2020 Q4	$4.89M	Sell	71,587 -9,507	-12%	-$618K	2.02%	14
2020 Q3	$4.74M	Buy	81,094 +78	+0.1%	+$4.85K	2.27%	10
2020 Q2	$5.26M	Sell	81,016 -701	-0.9%	-$44.1K	2.89%	7
2020 Q1	$4.85M	Buy	81,717 +8,846	+12%	+$591K	3.74%	5
2019 Q4	$5.41M	Buy	+72,871	New	+$5.12M	3.93%	6
2017 Q4	–	Sell	-12	Closed	-$1K	–	191
2017 Q3	$1K	Buy	+12	New	+$949	﹤0.01%	245

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Corbenic Partners's CVS Position: Q2 2022 in Review

Corbenic Partners reduced its CVS Health (CVS) stake by 0.91% in Q2 2022, selling an estimated $78.1K and leaving 86,888 shares worth $8.05M. The position accounts for 2.12% of the portfolio, ranked #16.

Corbenic Partners first reported a position in CVS in Q3 2017 and has held it in 12 quarters since. The position peaked at $9.59M in Q4 2021. 2,307 funds tracked by Wall St. Rank hold CVS as of Q2 2022.

Corbenic Partners held 86,888 shares of CVS Health worth $8.05M as of Q2 2022.
Corbenic Partners sold 800 CVS Health shares in Q2 2022, an estimated $78.1K.
CVS Health made up 2.12% of Corbenic Partners's portfolio in Q2 2022, its #16 holding.
Corbenic Partners first reported a position in CVS Health in Q3 2017 and has held it in 12 quarters since.
Corbenic Partners's CVS Health position peaked at $9.59M in Q4 2021.
2,307 funds tracked by Wall St. Rank held CVS Health as of Q2 2022.

Based on Corbenic Partners's 13F filing for Q2 2022, filed 25 Jul 2022.